VR purpose here is to describe the first exploratory steps we have taken in man leading to the use of a beam of slow neutrons from a nuclear reactor (atomic pile) in an effort to improve the treatment of neoplasms. The nuclei of certain atoms have a pronounced tendency to capture these slow neutrons, breaking down and yielding lethal amounts of energy. We propose to indicate how this energy may perhaps be channeled usefully to destroy tumors.
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Efforts to accomplish this by energies liberated at nuclear disintegration of radioactive isotopes have to date been discouraging except in radioactiize treatment of metastases of carcinoma of the thyroid. The problem of making the isotope concentrate in the tumor to a usefully greater degree than in any other cells of the body is the one that has not yet been solved. The rapidly metabolizing hepatic cells, the gastro-intestinal mucosal cells, the white blood cells and precursors of the red blood cells all appear to take up intravenously injected isotopes about as fast as, or even faster than malignant tumors. When enormous differentials were found in radioactive p82 uptake between intracranial tumors and normal brain 9 it was at first hoped that this might lead to useful therapy since the high energy fl particles (electrons) emitted by the decaying p32 could travel only a few millimeters in tissue and their destructive effect in the head would hence be confined largely to tumor, sparing most of the normal brain. However, as Table 1 shows, liver and bone marrow take up as much or more p32 than does a malignant glioma. In our hands and those of Erikson and Steelman, 2 p32 has in fact not proven helpful as thus far used in the treatment of brain tumors since the neoplastic cells have not shown a greater sensitivity to radiation than the normal cells of liver and bone marrow. The formidable character of the barrier between blood and normal brain as contrasted with the much more permeable barrier between blood and brain tumor is also attested to by studies with K 42 (Selverstone, Sweet and Ireton) 1~ and p1 in diiodofluorescein (Moore et al.) .4 At optimum times after intravenous injection t~ 42 may be found in intracranial tumors at concentrations exceeding 100 times those in normal white matter and diiodofiuorescein may concentrate up to ~9 times as much in brain tumors as in normal brain.
It would appear that we can utilize this difference between the bloodbrain and the blood-brain tumor barrier if we can find some stable atom which will concentrate in a brain tumor but which can then be made to disintegrate by an appropriate neutron radiation confined to the head and yielding large amounts of energy in the head only. The amounts of this special atom elsewhere in the body would be immaterial since other areas would be outside the destroying ionizing effect of the neutron beam. The intraeranial gliomas and meningiomas are likely candidates for this form of attack since with few exceptions they do not grow elsewhere in the body and since the treatment of gliomas is notoriously in need of improvement. It was indicated as early as 1940 both by Kruger 3 and by Zahl et al. ia that substances that yield energetic atomic particles when they capture very slow (thermal) neutrons might be useful in the treatment of cancer. Among the requirements for advancement in this direction are: (1) An adequate source of slow neutrons. (r A method for distributing throughout tumor but not normal tissue an isotope that avidly captures neutrons. (3) Determination of the absolute concentration of such an isotope in various tissues that would be required to enable a neutron beam of given intensity to kill the neoplastic cells but spare the normal ones, The intense flux of neutrons required is now available at the nuclear reactor at the Brookhaven National Laboratories. Before indicating our efforts regarding steps ~ and 8 we shall summarize some of the pertinent facts of nuclear physics and biology.
Most of the nuclear radiations, i.e. gamma rays, beta particles, alpha particles (helium atoms with a double positive charge), protons and fast neutrons, are usually produced at radioactive decay with large energies ranging up into a few millions of electron volts (mev). When rays or particles at these high energies react with
